NASDAQ:CUTR - Cutera Stock Price, News, & Analysis

Get Started

$20.84 -0.46 (-2.16 %)

(As of 10/23/2018 06:00 AM ET)

Previous Close$21.30

Today's Range$20.81 - $21.45

52-Week Range$20.75 - $56.05

Volume123,444 shs

Average Volume284,516 shs

Market Capitalization$294.72 million

P/E Ratio48.41

Dividend YieldN/A

Beta0.31

Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin rejuvenation. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; and CoolGlide, as well as myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Electromedical equipment

Sub-IndustryN/A

SectorComputer and Technology

SymbolNASDAQ:CUTR

CUSIPN/A

Webwww.cutera.com

Phone415-657-5500

Debt

Debt-to-Equity RatioN/A

Current Ratio1.98

Quick Ratio1.28

Price-To-Earnings

Trailing P/E Ratio48.41

Forward P/E Ratio-65.13

P/E GrowthN/A

Sales & Book Value

Annual Sales$151.49 million

Price / Sales1.90

Cash Flow$0.8658 per share

Price / Cash24.07

Book Value$4.68 per share

Price / Book4.45

Profitability

EPS (Most Recent Fiscal Year)$0.77

Net Income$29.99 million

Net Margins15.67%

Return on Equity10.21%

Return on Assets6.17%

Miscellaneous

Employees367

Outstanding Shares13,840,000

Market Cap$294.72 million

Cutera (NASDAQ:CUTR) Frequently Asked Questions

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

How will Cutera's stock buyback program work?

Cutera declared that its board has authorized a share buyback program on Tuesday, August 8th 2017, which authorizes the company to buyback $25,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its stock is undervalued.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) issued its earnings results on Tuesday, August, 7th. The medical device company reported $0.12 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.18 by $0.06. The medical device company had revenue of $42.55 million for the quarter, compared to the consensus estimate of $41.50 million. Cutera had a net margin of 15.67% and a return on equity of 10.21%. View Cutera's Earnings History.

When is Cutera's next earnings date?

Cutera is scheduled to release their next quarterly earnings announcement on Tuesday, November 6th 2018. View Earnings Estimates for Cutera.

How can I listen to Cutera's earnings call?

Cutera will be holding an earnings conference call on Tuesday, November 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has Cutera issued on next quarter's earnings?

Cutera issued an update on its FY 2018 earnings guidance on Monday, October, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $165-170 million, compared to the consensus revenue estimate of $178.56 million.Cutera also updated its Q3 2018 guidance to EPS.

What price target have analysts set for CUTR?

5 brokerages have issued 1-year price objectives for Cutera's stock. Their forecasts range from $24.94 to $50.00. On average, they anticipate Cutera's stock price to reach $34.6467 in the next twelve months. This suggests a possible upside of 66.3% from the stock's current price. View Analyst Price Targets for Cutera.

What is the consensus analysts' recommendation for Cutera?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cutera.

What are Wall Street analysts saying about Cutera stock?

Here are some recent quotes from research analysts about Cutera stock:

1. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (8/13/2018)
2. Gabelli analysts commented, "As a leading laser dermatology company, Cutera is an attractive long-term investment as management focuses on execution, growing sales and improving operating performance. Throughout 2017, Cutera revamped several members of its management team, including its CEO and CFO, along with several new hires to build out its sales and operational infrastructure in the US and internationally. Management is putting in place new processes to improve upon product development and scale up its organization for sustainable growth." (2/16/2018)
3. Maxim Group analysts commented, "3Q17 total revenue of $38.2M, up 26.1% y/y, was above both our estimate of $35.6M and consensus of $34.7M. North America product revenue grew 57.4% y/y, while international product revenue grew just 0.1% y/y." (11/8/2017)

Who are some of Cutera's key competitors?

Some companies that are related to Cutera include Natus Medical (BABY), Viewray (VRAY), Electrocore (ECOR), Vision Sciences (CGNT), Semler Scientific (SMLR), Rockwell Medical (RMTI), BioLife Solutions (BLFS), Helius Medical Technologies (HSDT), Fonar (FONR), Viveve Medical (VIVE), Zynex (ZYXI), Second Sight Medical Products (EYES), Edap Tms (EDAP), Stereotaxis (STXS) and IRIDEX (IRIX).

Who are Cutera's key executives?

Cutera's management team includes the folowing people:

Mr. James A. Reinstein, CEO, Pres & Director (Age 53)
Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 52)
Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 47)
Mr. Ronald J. Santilli, Exec. Officer (Age 58)
Mr. Jason Richey, Chief Operating Officer

Who are Cutera's major shareholders?

Cutera's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (2.66%), Essex Investment Management Co. LLC (0.86%), Strs Ohio (0.65%) and NJ State Employees Deferred Compensation Plan (0.13%). Company insiders that own Cutera stock include David A Gollnick, David B Apfelberg, Gregory A Barrett, J Daniel Plants, James A Reinstein, Larry Laber, Miguel Pardos, Ronald J Santilli and Timothy J Oshea. View Institutional Ownership Trends for Cutera.

Which institutional investors are selling Cutera stock?

CUTR stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio. Company insiders that have sold Cutera company stock in the last year include David A Gollnick, David B Apfelberg, James A Reinstein, Larry Laber, Miguel Pardos and Timothy J Oshea. View Insider Buying and Selling for Cutera.

Which institutional investors are buying Cutera stock?

CUTR stock was acquired by a variety of institutional investors in the last quarter, including NJ State Employees Deferred Compensation Plan, Essex Investment Management Co. LLC and Peregrine Capital Management LLC. Company insiders that have bought Cutera stock in the last two years include Gregory A Barrett and James A Reinstein. View Insider Buying and Selling for Cutera.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $20.84.

How big of a company is Cutera?

Cutera has a market capitalization of $294.72 million and generates $151.49 million in revenue each year. The medical device company earns $29.99 million in net income (profit) each year or $0.77 on an earnings per share basis. Cutera employs 367 workers across the globe.

What is Cutera's official website?

The official website for Cutera is http://www.cutera.com.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]

MarketBeat Community Rating for Cutera (NASDAQ CUTR)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		221 (Vote Outperform)
Underperform Votes:		198 (Vote Underperform)
Total Votes:		419

MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe CUTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUTR will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 10/23/2018 by MarketBeat.com Staff